CancerConnect

A targeted medicine called sunvozertinib helped patients with advanced non-small cell lung cancer (NSCLC) containing an EGFR exon 20 insertion mutation live longer without their cancer worsening compared to standard platinum-based chemotherapy in a large international clinical trial. The findings come from the phase 3 WU-KONG28 study, which compared sunvozertinib with carbopl...

September has been designated “blood cancer awareness month” by the Leukemia and Lymphoma Society. Blood cancers rarely produce signs or symptoms until they are very advanced. They are typically discovered by doctors performing routine blood work for other reasons or because of swelling of the lymph nodes.

As the month of September brings...

As the month of September brings prostate cancer into focus, it’s a great time to increase understanding of the disease and highlight the many recent advances in the management of prostate cancer. Prostate cancer remains the most frequently diagnosed cancer in men and is a leading cause of cancer death in men.

September has been designated “blood cancer awareness month” by the Leukemia and Lymphoma Society. Blood cancers rarely produce signs or symptoms until they are very advanced. They are typically discovered by doctors performing routine blood work for other reasons or because of swelling of the lymph nodes.

As the month of September brings blood cancers into focus, Canc...

September has been designated “blood cancer awareness month” by the Leukemia and Lymphoma Society. Blood cancers rarely produce signs or symptoms until they are very advanced. They are typically discovered by doctors performing routine blood work for other reasons or because of swelling of the lymph nodes.

Myeloproliferative neoplasms (MP...